Oxymorphone HCL ER 20 MG tab 60S
Ended Awarded
- Contract number
- SPE2DB25FWJPA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,870
Award facts
- Contract value 100% obligated
- $2,869.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Oxymorphone HCL ER 20 mg tablets (60-count packages) with a ceiling value of $2,869.54. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle valued through December 2026 that enables the distributor to supply a broad range of medications and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. As a competitively awarded prime contractor, the company demonstrates extensive capability in fulfilling federal medical supply requirements across multiple therapeutic domains, with contract awards ranging from small-value transactions to substantial orders exceeding $45,000. The delivery order for controlled pharmaceutical products reflects the company's established role within the DLA's medical supply chain and its ongoing support to defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FWJPA?
SPE2DB25FWJPA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FWJPA worth?
The government has obligated $2,870 on SPE2DB25FWJPA.
Is contract SPE2DB25FWJPA an order under another contract?
Yes. SPE2DB25FWJPA is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWJPA competed?
The extent of competition for SPE2DB25FWJPA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award